Fixed-dose tablets featuring alpha-glucosidase inhibitor and biguanide for diabetes control. Supplied by pharmaceutical producers to supply chains ser...

Combination therapy tablets featuring SGLT2 inhibitor dapagliflozin alongside metformin for adult type 2 diabetes. Manufactured for export and domesti...

Combination tablets incorporating sulfonylurea glibenclamide with metformin hydrochloride for type 2 diabetes control. Distributed by wholesale pharma...

Fixed-dose tablets merging sulfonylurea gliclazide and metformin for treating type 2 diabetes mellitus. Supplied by pharmaceutical producers to bulk b...

Fixed-dose combination tablets of sulfonylurea and biguanide, used in type 2 diabetes glycemic control. Sourced from pharmaceutical suppliers, distrib...

Tablets combining DPP-4 inhibitor linagliptin and metformin HCl for managing type 2 diabetes in adults. Sourced from global and local drug manufacture...

Fixed-combination tablets of metformin and DPP-4 inhibitor teneligliptin for type 2 diabetes therapy. Formulated by API-integrated manufacturers, proc...

Fixed-dose combination tablets integrating sustained-release metformin with glimepiride and voglibose for type 2 diabetes management. Pharmaceutical m...

Combination oral tablets combining biguanide and thiazolidinedione for glycemic regulation in type 2 diabetes. Produced by generic drug firms for dist...

Fixed-dose combination tablets integrating biguanide and alpha-glucosidase inhibitor for type 2 diabetes management. Pharmaceutical manufacturers supp...

Combination tablets combining DPP-4 inhibitor sitagliptin with metformin hydrochloride for glycemic control in type 2 diabetes. Produced by generic an...

Dual-component tablets with DPP-4 inhibitor vildagliptin and metformin hydrochloride targeting hyperglycemia in type 2 diabetes. Pharmaceutical suppli...